- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有177家主力机构披露2026-06-30报告期持股数据，持仓量总计6.50亿股，占流通A股62.64%
- 波段诊断：
-
技术面诊股
诊断结果：6.2技术面打败了71%的股票
技术面评分前10的股票
近期的平均成本为16.00元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为16.00元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"16.00","date":1788149435,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑赢行业平均水平。
[{"date":"2026.08.31","stock":"-0.50","trade":"-1.47","ind":"0.86"},{"date":"2026.08.28","stock":"0.06","trade":"-0.76","ind":"-0.11"},{"date":"2026.08.27","stock":"-0.37","trade":"1.37","ind":"1.13"},{"date":"2026.08.26","stock":"1.25","trade":"0.02","ind":"0.59"},{"date":"2026.08.25","stock":"1.14","trade":"2.42","ind":"0.19"},{"date":"2026.08.24","stock":"1.02","trade":"-2.88","ind":"-0.59"},{"date":"2026.08.21","stock":"-3.33","trade":"-3.66","ind":"0.04"},{"date":"2026.08.20","stock":"2.21","trade":"3.82","ind":"0.24"},{"date":"2026.08.19","stock":"-0.69","trade":"-2.08","ind":"-2.40"},{"date":"2026.08.18","stock":"-0.56","trade":"-0.60","ind":"0.19"},{"date":"2026.08.17","stock":"0.37","trade":"0.71","ind":"1.41"},{"date":"2026.08.14","stock":"-2.56","trade":"-0.46","ind":"0.01"},{"date":"2026.08.13","stock":"0.18","trade":"1.38","ind":"-0.50"},{"date":"2026.08.12","stock":"0.06","trade":"0.65","ind":"0.32"},{"date":"2026.08.11","stock":"-0.12","trade":"0.17","ind":"-0.82"},{"date":"2026.08.10","stock":"0.24","trade":"1.23","ind":"0.67"},{"date":"2026.08.07","stock":"2.25","trade":"4.40","ind":"1.02"},{"date":"2026.08.06","stock":"-1.11","trade":"0.12","ind":"0.57"},{"date":"2026.08.05","stock":"-0.74","trade":"0.50","ind":"1.47"},{"date":"2026.08.04","stock":"-0.06","trade":"2.05","ind":"0.33"},{"date":"2026.08.03","stock":"0.25","trade":"0.60","ind":"-0.59"}]
华润双鹤,上证指数,化学制药指数
压力支撑
该股压力位为15.99元，支撑位为15.88元。
[{"text":"\u538b\u529b\u4f4d","value":"15.99","date":1788105600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.88","date":1788105600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.6资金面打败了49%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月01日 12:52
| 机构今日流向(万元) | -1855.45 | 机构5日流向(万元) | -5127.31 |
| 机构10日流向(万元) | -17470.15 | 机构20日流向(万元) | -21408.79 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1022.93万股，其中基金净减仓53家，主力净减仓34家，请投资者中长期谨慎为宜。
截止2026-06-30，共177家主力机构（基金173家，一般法人3家，阳光私募1家），持仓量总计65032.99万股，占流通A股62.64%
其中，基金持仓与2025-12-31相比：
增仓：29家 ，增持 52.64万股
减仓：82家 ，减持 730.12万股
新出现在主力名单中：48家 ，持有311.37万股
从主力名单中消失：82家 ，原持有396.52万股
其中，基金持仓与2025-12-31相比：
增仓：29家 ，增持 52.64万股
减仓：82家 ，减持 730.12万股
新出现在主力名单中：48家 ，持有311.37万股
从主力名单中消失：82家 ，原持有396.52万股
消息面诊股
诊断结果：6.8消息面打败了84%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 华润双鹤：8月31日获融资买入872.31万元
2026-09-01 - 华润双鹤：控股子公司0.15g奥卡西平片获药品注册
2026-08-31 - 华润双鹤：公司将结合财务状况、发展战略等综合因素，
2026-08-31 - 文兴：在隐秘的角落寻找长坡厚雪
2026-08-29 - 华润双鹤：8月28日获融资买入455.63万元
2026-08-29 - 华润双鹤：8月27日获融资买入843.37万元
2026-08-28 - 华润双鹤：8月26日获融资买入1333.29万元
2026-08-27 - 中国中药行业资本市场：集采全覆盖，并购整合提速，I
2026-08-26 - 华润双鹤：8月25日获融资买入514.72万元
2026-08-26 - 华润8大上市药企，最新业绩曝光
2026-08-25
消息列表
| 利好 | 分红转增 | 10派1元(含税) | 2026-08-22 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-08-05 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-07-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-06-26 |
| 一般消息 | 重大事项 | 关联交易 | 2026-06-26 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-05-19 |
| 利好 | 分红转增 | 10派3.79元(含税) | 2026-03-20 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-24 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-06 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-27 |
| 一般消息 | 高管变动 | 工作安排 | 2025-12-25 |
| 一般消息 | 高管变动 | 工作安排 | 2025-09-05 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.2行业面打败了67%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.08.31","price":"0.86","value":"-1.47"},{"date":"2026.08.28","price":"-0.11","value":"-0.76"},{"date":"2026.08.27","price":"1.13","value":"1.37"},{"date":"2026.08.26","price":"0.59","value":"0.02"},{"date":"2026.08.25","price":"0.19","value":"2.42"},{"date":"2026.08.24","price":"-0.59","value":"-2.88"},{"date":"2026.08.21","price":"0.04","value":"-3.66"},{"date":"2026.08.20","price":"0.24","value":"3.82"},{"date":"2026.08.19","price":"-2.40","value":"-2.08"},{"date":"2026.08.18","price":"0.19","value":"-0.60"},{"date":"2026.08.17","price":"1.41","value":"0.71"},{"date":"2026.08.14","price":"0.01","value":"-0.46"},{"date":"2026.08.13","price":"-0.50","value":"1.38"},{"date":"2026.08.12","price":"0.32","value":"0.65"},{"date":"2026.08.11","price":"-0.82","value":"0.17"},{"date":"2026.08.10","price":"0.67","value":"1.23"},{"date":"2026.08.07","price":"1.02","value":"4.40"},{"date":"2026.08.06","price":"0.57","value":"0.12"},{"date":"2026.08.05","price":"1.47","value":"0.50"},{"date":"2026.08.04","price":"0.33","value":"2.05"},{"date":"2026.08.03","price":"-0.59","value":"0.60"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 神奇制药 | 123.65% | 12.73% | 5.6分 |
| 2 | 冀衡医药 | 56.55% | 32.24% | 4.8分 |
| 3 | 哈药股份 | 52.25% | 10.95% | 6.0分 |
| 4 | 誉衡药业 | 51.74% | 10.91% | 5.2分 |
| 5 | 键凯科技 | 45.86% | -26.61% | 5.0分 |
| 6 | 东亚药业 | 32.46% | 4.99% | 5.2分 |
| 8 | - | 30.89% | -2.72% | 分 |
| 10 | 西点药业 | 25.17% | -9.07% | 4.8分 |
| 12 | 石药创新 | 21.70% | -2.30% | 5.8分 |
| 14 | 永安药业 | 20.52% | 0.66% | 5.7分 |
| 16 | ST天圣 | 18.02% | 12.03% | 5.0分 |
| 18 | 花园生物 | 17.45% | 4.24% | 4.9分 |
| 20 | 莱美药业 | 15.59% | 12.18% | 6.0分 |
| 22 | ST复华 | 14.29% | 10.07% | 4.8分 |
| 24 | 必贝特 | 14.25% | -1.79% | 5.0分 |
| 26 | 多瑞医药 | 13.58% | 7.53% | 4.9分 |
| 28 | 汉商集团 | 13.06% | 6.28% | 5.9分 |
| 30 | 翰宇药业 | 12.33% | 3.56% | 5.0分 |
| 32 | 海森药业 | 11.39% | -1.47% | 4.7分 |
| 34 | 北陆药业 | 11.08% | -10.47% | 5.3分 |
| 36 | 凯因科技 | 10.60% | -0.55% | 4.2分 |
| 38 | 仟源医药 | 10.40% | -6.50% | 5.5分 |
| 40 | 纳微科技 | 10.17% | -9.98% | 4.4分 |
| 42 | 本立科技 | 9.99% | 5.41% | 5.3分 |
| 44 | 华纳药厂 | 9.89% | 7.66% | 5.7分 |
| 46 | 泽璟制药 | 9.47% | -0.20% | 5.6分 |
| 48 | 富祥股份 | 8.39% | 0.94% | 5.3分 |
| 50 | 尔康制药 | 8.17% | 4.42% | 5.4分 |
| 52 | 百济神州 | 8.10% | -2.46% | 5.0分 |
| 54 | - | 7.62% | 1.96% | 分 |
| 56 | 汇宇制药 | 7.36% | -4.24% | 4.3分 |
| 58 | - | 7.09% | 1.31% | 分 |
| 60 | 富士莱 | 6.31% | 0.15% | 5.2分 |
| 62 | 东北制药 | 6.06% | 0.41% | 5.3分 |
| 64 | 天宇股份 | 6.00% | -0.42% | 5.1分 |
| 66 | 益方生物 | 5.75% | 4.25% | 4.7分 |
| 68 | 金陵药业 | 5.66% | 3.23% | 5.4分 |
| 70 | 润都股份 | 5.62% | 1.84% | 5.5分 |
| 72 | 浙江医药 | 5.46% | 3.03% | 5.3分 |
| 74 | ST人福 | 5.20% | 4.26% | 5.7分 |
| 76 | 首药控股 | 5.03% | -7.73% | 4.0分 |
| 78 | 博瑞医药 | 4.83% | 4.89% | 4.6分 |
| 80 | 罗欣药业 | 4.09% | 3.86% | 4.5分 |
| 82 | 鲁抗医药 | 4.02% | 7.93% | 5.8分 |
| 84 | 上海谊众 | 4.00% | 6.33% | 4.6分 |
| 86 | 圣诺生物 | 3.91% | -2.23% | 5.2分 |
| 88 | ST诺泰 | 3.63% | 2.14% | 5.0分 |
| 90 | 海普瑞 | 3.40% | 0.40% | 5.1分 |
| 92 | 前沿生物 | 3.04% | -7.93% | 4.1分 |
| 94 | 广生堂 | 2.92% | 1.84% | 4.4分 |
| 96 | 海翔药业 | 2.36% | 11.68% | 5.4分 |
| 98 | ST南新 | 2.12% | 6.14% | 4.2分 |
| 100 | 康芝药业 | 2.01% | 2.80% | 5.4分 |
| 102 | 津药药业 | 1.53% | 2.90% | 4.5分 |
| 104 | 奥翔药业 | 1.31% | -2.64% | 4.2分 |
| 106 | 昂利康 | 1.01% | -1.54% | 4.4分 |
| 108 | 同和药业 | 0.73% | 0.88% | 4.9分 |
| 110 | 辰欣药业 | 0.48% | 7.64% | 4.9分 |
| 112 | - | 0.42% | 1.97% | 分 |
| 114 | 九典制药 | -0.09% | 1.10% | 5.0分 |
| 116 | 东诚药业 | -0.69% | 0.70% | 5.8分 |
| 118 | 共同药业 | -1.22% | -0.45% | 4.7分 |
| 120 | 苑东生物 | -1.39% | 2.54% | 4.5分 |
| 122 | 华北制药 | -1.44% | 3.90% | 4.8分 |
| 124 | 奥锐特 | -1.54% | 2.05% | 4.6分 |
| 126 | 力生制药 | -1.81% | 2.24% | 5.1分 |
| 128 | 微芯生物 | -1.89% | -1.82% | 4.5分 |
| 130 | 溢多利 | -2.40% | -8.21% | 4.7分 |
| 132 | 健友股份 | -2.93% | 2.06% | 5.0分 |
| 134 | 复星医药 | -3.41% | -1.89% | 4.8分 |
| 136 | 泰恩康 | -3.62% | 5.78% | 5.3分 |
| 138 | 信立泰 | -3.89% | 0.92% | 5.3分 |
| 140 | 华东医药 | -4.59% | 0.41% | 5.3分 |
| 142 | 通化金马 | -4.77% | 5.61% | 5.5分 |
| 144 | 联环药业 | -5.40% | 3.01% | 5.1分 |
| 146 | 福元医药 | -5.84% | 1.75% | 4.7分 |
| 148 | 常山药业 | -6.19% | 1.15% | 4.5分 |
| 150 | 百利天恒 | -6.30% | 0.70% | 4.8分 |
| 152 | 健康元 | -10.23% | -1.50% | 4.8分 |
| 154 | 新和成 | -11.32% | 2.66% | 5.8分 |
| 156 | 恒瑞医药 | -13.08% | -1.48% | 4.7分 |
| 158 | 丽珠集团 | -14.86% | 0.27% | 5.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/214 ， 53/214。
[{"date":"2026-06-30","value":"7.92","vol":"-0.16"},{"date":"2026-03-31","value":"4.08","vol":"0.45"},{"date":"2025-12-31","value":"14.94","vol":"-1.85"},{"date":"2025-09-30","value":"12.42","vol":"1.60"},{"date":"2025-06-30","value":"9.10","vol":"1.26"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.92 | 4.08 | 14.94 | 12.42 | 9.10 |
| 行业(%) | -0.16 | 0.45 | -1.85 | 1.60 | 1.26 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"58.11","vol":"49.70"},{"date":"2026-03-31","value":"59.03","vol":"50.98"},{"date":"2025-12-31","value":"58.01","vol":"49.96"},{"date":"2025-09-30","value":"59.31","vol":"49.79"},{"date":"2025-06-30","value":"59.80","vol":"49.69"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
58.11 | 59.03 | 58.01 | 59.31 | 59.80 |
| 行业(%) | 49.70 | 50.98 | 49.96 | 49.79 | 49.69 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 91/214 ， 77/214。
[{"date":"2026-06-30","value":"-3.44","vol":"20.52"},{"date":"2026-03-31","value":"-8.84","vol":"24.44"},{"date":"2025-12-31","value":"-1.88","vol":"38.58"},{"date":"2025-09-30","value":"-3.10","vol":"142.64"},{"date":"2025-06-30","value":"-3.16","vol":"79.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-3.44 | -8.84 | -1.88 | -3.10 | -3.16 |
| 行业(%) | 20.52 | 24.44 | 38.58 | 142.64 | 79.18 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-3.43","vol":"371.05"},{"date":"2026-03-31","value":"-4.30","vol":"52.58"},{"date":"2025-12-31","value":"1.18","vol":"-24.51"},{"date":"2025-09-30","value":"-3.40","vol":"3.72"},{"date":"2025-06-30","value":"-6.79","vol":"66.32"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-3.43 | -4.30 | 1.18 | -3.40 | -6.79 |
| 行业(%) | 371.05 | 52.58 | -24.51 | 3.72 | 66.32 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/214 ， 40/214。
[{"date":"2026-06-30","value":"0.32","vol":"0.21"},{"date":"2026-03-31","value":"0.16","vol":"0.10"},{"date":"2025-12-31","value":"0.65","vol":"0.41"},{"date":"2025-09-30","value":"0.49","vol":"0.31"},{"date":"2025-06-30","value":"0.34","vol":"0.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.32 | 0.16 | 0.65 | 0.49 | 0.34 |
| 行业(次) | 0.21 | 0.10 | 0.41 | 0.31 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.51","vol":"1.27"},{"date":"2026-03-31","value":"0.75","vol":"0.64"},{"date":"2025-12-31","value":"2.91","vol":"2.56"},{"date":"2025-09-30","value":"2.08","vol":"1.94"},{"date":"2025-06-30","value":"1.43","vol":"1.30"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.51 | 0.75 | 2.91 | 2.08 | 1.43 |
| 行业(次) | 1.27 | 0.64 | 2.56 | 1.94 | 1.30 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 77/214 ， 56/214。
[{"date":"2026-06-30","value":"16.05","vol":"4.52"},{"date":"2026-03-31","value":"6.08","vol":"-2.75"},{"date":"2025-12-31","value":"12.60","vol":"16.48"},{"date":"2025-09-30","value":"19.08","vol":"4.59"},{"date":"2025-06-30","value":"12.96","vol":"2.93"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 16.05 | 6.08 | 12.60 | 19.08 | 12.96 |
| 行业 | 4.52 | -2.75 | 16.48 | 4.59 | 2.93 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.59","vol":"1.32"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.78","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.62","vol":"1.72"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.59 | - | 0.78 | - | 0.62 |
| 行业 | 1.32 | 0.00 | 1.60 | 0.00 | 1.72 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/214 ， 77/214。
[{"date":"2026-06-30","value":"2.16","vol":"3.49"},{"date":"2026-03-31","value":"2.67","vol":"3.58"},{"date":"2025-12-31","value":"2.35","vol":"3.33"},{"date":"2025-09-30","value":"2.25","vol":"3.50"},{"date":"2025-06-30","value":"2.23","vol":"3.68"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.16 | 2.67 | 2.35 | 2.25 | 2.23 |
| 行业 | 3.49 | 3.58 | 3.33 | 3.50 | 3.68 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.68","vol":"2.80"},{"date":"2026-03-31","value":"2.05","vol":"2.94"},{"date":"2025-12-31","value":"1.75","vol":"2.71"},{"date":"2025-09-30","value":"1.64","vol":"2.75"},{"date":"2025-06-30","value":"1.67","vol":"2.90"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.68 | 2.05 | 1.75 | 1.64 | 1.67 |
| 行业 | 2.80 | 2.94 | 2.71 | 2.75 | 2.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/214 ， 73/214。
[{"date":"2026-06-30","value":"28.45","vol":"33.54"},{"date":"2026-03-31","value":"27.79","vol":"33.40"},{"date":"2025-12-31","value":"26.51","vol":"34.57"},{"date":"2025-09-30","value":"28.52","vol":"34.00"},{"date":"2025-06-30","value":"29.65","vol":"34.11"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
28.45 | 27.79 | 26.51 | 28.52 | 29.65 |
| 行业(%) | 33.54 | 33.40 | 34.57 | 34.00 | 34.11 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.43","vol":"0.71"},{"date":"2026-03-31","value":"0.41","vol":"9.83"},{"date":"2025-12-31","value":"0.39","vol":"1.77"},{"date":"2025-09-30","value":"0.43","vol":"1.19"},{"date":"2025-06-30","value":"0.45","vol":"0.88"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.43 | 0.41 | 0.39 | 0.43 | 0.45 |
| 行业(%) | 0.71 | 9.83 | 1.77 | 1.19 | 0.88 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"11.64","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"13.33","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"16.28","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"16.47","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"17.97","blueLineValue":"1.73","type":"YC"}]